Stock Events

Stock Events

Search...

Galmed Pharmaceuticals (GLMD) Q3 2025 Earnings

28AugConfirmed

Q4 2024

Q2 2025

Q2 2025

Q3 2025

-1.94

-1.5

-1.06

-0.62

Details

Expected EPS

-0.83

Actual EPS

-0.63

Surprise EPS

0.2

Surprise Percent

+24.1%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -0.63 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.